메뉴 건너뛰기




Volumn 1852, Issue 12, 2015, Pages 2662-2670

Inhibition of cereblon by fenofibrate ameliorates alcoholic liver disease by enhancing AMPK

Author keywords

Cytokine; Gene expression; Inflammation; PPAR ; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CEREBLON; CYTOCHROME P450 2E1; CYTOKINE; FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; UNCLASSIFIED DRUG;

EID: 84942848660     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.09.014     Document Type: Article
Times cited : (19)

References (38)
  • 1
    • 80054872790 scopus 로고    scopus 로고
    • Alcoholic liver disease: pathogenesis and new therapeutic targets
    • Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1582.
    • (2011) Gastroenterology , vol.141 , pp. 1572-1582
    • Gao, B.1    Bataller, R.2
  • 3
    • 12744267799 scopus 로고    scopus 로고
    • Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha
    • Crabb D.W., Galli A., Fischer M., You M. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol 2004, 34:35-38.
    • (2004) Alcohol , vol.34 , pp. 35-38
    • Crabb, D.W.1    Galli, A.2    Fischer, M.3    You, M.4
  • 5
    • 79952227694 scopus 로고    scopus 로고
    • Nuclear receptors in liver disease
    • Wagner M., Zollner G., Trauner M. Nuclear receptors in liver disease. Hepatology 2011, 53:1023-1034.
    • (2011) Hepatology , vol.53 , pp. 1023-1034
    • Wagner, M.1    Zollner, G.2    Trauner, M.3
  • 6
    • 80054770307 scopus 로고    scopus 로고
    • Pathways of liver injury in alcoholic liver disease
    • Tilg H., Moschen A.R., Kaneider N.C. Pathways of liver injury in alcoholic liver disease. J. Hepatol. 2011, 55:1159-1161.
    • (2011) J. Hepatol. , vol.55 , pp. 1159-1161
    • Tilg, H.1    Moschen, A.R.2    Kaneider, N.C.3
  • 7
    • 84879283106 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases
    • Monsalve F.A., Pyarasani R.D., Delgado-Lopez F., Moore-Carrasco R. Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases. Mediat. Inflamm. 2013, 2013:1-18.
    • (2013) Mediat. Inflamm. , vol.2013 , pp. 1-18
    • Monsalve, F.A.1    Pyarasani, R.D.2    Delgado-Lopez, F.3    Moore-Carrasco, R.4
  • 8
    • 84891702448 scopus 로고    scopus 로고
    • PPAR-α as a key nutritional and environmental sensor for metabolic adaptation
    • Contreras A.V., Torres N., Tovar A.R. PPAR-α as a key nutritional and environmental sensor for metabolic adaptation. Adv. Nutr. 2013, 4:439-452.
    • (2013) Adv. Nutr. , vol.4 , pp. 439-452
    • Contreras, A.V.1    Torres, N.2    Tovar, A.R.3
  • 9
    • 0000548749 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
    • Pineda Torra I., Gervois P., Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging. Curr. Opin. Lipidol. 1999, 10:151-159.
    • (1999) Curr. Opin. Lipidol. , vol.10 , pp. 151-159
    • Pineda Torra, I.1    Gervois, P.2    Staels, B.3
  • 10
    • 80053185929 scopus 로고    scopus 로고
    • Fenofibrate: a review of its use in dyslipidaemia
    • McKeage K., Keating G.M. Fenofibrate: a review of its use in dyslipidaemia. Drugs 2011, 71:1917-1946.
    • (2011) Drugs , vol.71 , pp. 1917-1946
    • McKeage, K.1    Keating, G.M.2
  • 11
    • 33646393509 scopus 로고    scopus 로고
    • Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance
    • Okopień B., Krysiak R., Herman Z.S. Effects of short-term fenofibrate treatment on circulating markers of inflammation and hemostasis in patients with impaired glucose tolerance. J. Clin. Endocrinol. Metab. 2006, 91:1770-1778.
    • (2006) J. Clin. Endocrinol. Metab. , vol.91 , pp. 1770-1778
    • Okopień, B.1    Krysiak, R.2    Herman, Z.S.3
  • 12
    • 84878218164 scopus 로고    scopus 로고
    • Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress
    • Chan S.M., Sun R.Q., Zeng X.Y., Choong Z.H., Wang H., Watt M.J., Ye J.M. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013, 62:2095-2105.
    • (2013) Diabetes , vol.62 , pp. 2095-2105
    • Chan, S.M.1    Sun, R.Q.2    Zeng, X.Y.3    Choong, Z.H.4    Wang, H.5    Watt, M.J.6    Ye, J.M.7
  • 13
    • 70349260288 scopus 로고    scopus 로고
    • Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner
    • Chanda D., Lee C.H., Kim Y.H., Nor J.R., Kim D.K., Park J.H., Hwang J.H., Lee M.R., Jeong K.H., Lee I.K., Kweon G.R., Shong M., Oh G.T., Chiang J.Y., Choi H.S. Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate-activated protein kinase-dependent induction of orphan nuclear receptor small heterodimer partner. Hepatology 2009, 50:880-892.
    • (2009) Hepatology , vol.50 , pp. 880-892
    • Chanda, D.1    Lee, C.H.2    Kim, Y.H.3    Nor, J.R.4    Kim, D.K.5    Park, J.H.6    Hwang, J.H.7    Lee, M.R.8    Jeong, K.H.9    Lee, I.K.10    Kweon, G.R.11    Shong, M.12    Oh, G.T.13    Chiang, J.Y.14    Choi, H.S.15
  • 14
    • 79551581810 scopus 로고    scopus 로고
    • Functional modulation of AMP-activated protein kinase by cereblon
    • Lee K.M., Jo S., Kim H., Lee J., Park C.S. Functional modulation of AMP-activated protein kinase by cereblon. Biochim. Biophys. Acta 2011, 1813:448-455.
    • (2011) Biochim. Biophys. Acta , vol.1813 , pp. 448-455
    • Lee, K.M.1    Jo, S.2    Kim, H.3    Lee, J.4    Park, C.S.5
  • 16
    • 84878257427 scopus 로고    scopus 로고
    • Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice
    • Lee K.M., Yang S.J., Kim Y.D., Choi Y.D., Nam J.H., Choi C.S., Choi H.S., Park C.S. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice. Diabetes 2013, 62:1855-1864.
    • (2013) Diabetes , vol.62 , pp. 1855-1864
    • Lee, K.M.1    Yang, S.J.2    Kim, Y.D.3    Choi, Y.D.4    Nam, J.H.5    Choi, C.S.6    Choi, H.S.7    Park, C.S.8
  • 18
    • 65349177200 scopus 로고    scopus 로고
    • AMPK: an emerging drug target for diabetes and the metabolic syndrome
    • Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9:407-416.
    • (2009) Cell Metab. , vol.9 , pp. 407-416
    • Zhang, B.B.1    Zhou, G.2    Li, C.3
  • 19
  • 21
    • 84879104840 scopus 로고    scopus 로고
    • Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes
    • Jeong Y.T., Kim Y.D., Jung Y.M., Park D.C., Lee D.S., Ku S.K., Li X., Lu Y., Chao G.H., Kim K.J., Lee J.Y., Baek M.C., Kang W., Hwang S.L., Chang H.W. Low molecular weight fucoidan improves endoplasmic reticulum stress-reduced insulin sensitivity through AMP-activated protein kinase activation in L6 myotubes and restores lipid homeostasis in a mouse model of type 2 diabetes. Mol. Pharmacol. 2013, 84:147-157.
    • (2013) Mol. Pharmacol. , vol.84 , pp. 147-157
    • Jeong, Y.T.1    Kim, Y.D.2    Jung, Y.M.3    Park, D.C.4    Lee, D.S.5    Ku, S.K.6    Li, X.7    Lu, Y.8    Chao, G.H.9    Kim, K.J.10    Lee, J.Y.11    Baek, M.C.12    Kang, W.13    Hwang, S.L.14    Chang, H.W.15
  • 22
    • 84878806915 scopus 로고    scopus 로고
    • CAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis
    • Min A.K., Jeong J.Y., Go Y., Choi Y.K., Kim Y.D., Lee I.K., Park K.G. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis. Diabetologia 2013, 56:412-422.
    • (2013) Diabetologia , vol.56 , pp. 412-422
    • Min, A.K.1    Jeong, J.Y.2    Go, Y.3    Choi, Y.K.4    Kim, Y.D.5    Lee, I.K.6    Park, K.G.7
  • 23
    • 84862817442 scopus 로고    scopus 로고
    • Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models
    • Kim Y.D., Kim Y.H., Cho Y.M., Kim D.K., Ahn S.W., Lee J.M., Chanda D., Shong M., Lee C.H., Choi H.S. Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models. Diabetologia 2012, 55:1482-1494.
    • (2012) Diabetologia , vol.55 , pp. 1482-1494
    • Kim, Y.D.1    Kim, Y.H.2    Cho, Y.M.3    Kim, D.K.4    Ahn, S.W.5    Lee, J.M.6    Chanda, D.7    Shong, M.8    Lee, C.H.9    Choi, H.S.10
  • 24
    • 77956262273 scopus 로고    scopus 로고
    • Induction of cereblon by NF-E2-related factor 2 in neuroblastoma cells exposed to hypoxia-reoxygenation
    • Lee K.J., Lee K.M., Jo S., Kang K.W., Park C.S. Induction of cereblon by NF-E2-related factor 2 in neuroblastoma cells exposed to hypoxia-reoxygenation. Biochem. Biophys. Res. Commun. 2010, 399:711-715.
    • (2010) Biochem. Biophys. Res. Commun. , vol.399 , pp. 711-715
    • Lee, K.J.1    Lee, K.M.2    Jo, S.3    Kang, K.W.4    Park, C.S.5
  • 25
    • 78651399025 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db mice
    • Im S.S., Kim M.Y., Kwon S.K., Kim T.H., Bae J.S., Kim H., Kim K.S., Oh G.T., Ahn Y.H. Peroxisome proliferator-activated receptor {alpha} is responsible for the up-regulation of hepatic glucose-6-phosphatase gene expression in fasting and db/db mice. J. Biol. Chem. 2011, 286:1157-1164.
    • (2011) J. Biol. Chem. , vol.286 , pp. 1157-1164
    • Im, S.S.1    Kim, M.Y.2    Kwon, S.K.3    Kim, T.H.4    Bae, J.S.5    Kim, H.6    Kim, K.S.7    Oh, G.T.8    Ahn, Y.H.9
  • 27
    • 75149117805 scopus 로고    scopus 로고
    • Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1
    • Yamada E., Pessin J.E., Kurland I.J., Schwartz G.J., Bastie C.C. Fyn-dependent regulation of energy expenditure and body weight is mediated by tyrosine phosphorylation of LKB1. Cell Metab. 2010, 11:113-124.
    • (2010) Cell Metab. , vol.11 , pp. 113-124
    • Yamada, E.1    Pessin, J.E.2    Kurland, I.J.3    Schwartz, G.J.4    Bastie, C.C.5
  • 28
    • 70449365855 scopus 로고    scopus 로고
    • Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?
    • Vatish M., Yamada E., Pessin J.E., Bastie C.C. Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?. Arch. Physiol. Biochem. 2009, 115:191-198.
    • (2009) Arch. Physiol. Biochem. , vol.115 , pp. 191-198
    • Vatish, M.1    Yamada, E.2    Pessin, J.E.3    Bastie, C.C.4
  • 30
    • 77249094005 scopus 로고    scopus 로고
    • Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice
    • Shen Z., Liang X., Rogers C.Q., Rideout D., You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver. Physiol. 2010, 298:G364-G374.
    • (2010) Am. J. Physiol. Gastrointest. Liver. Physiol. , vol.298 , pp. G364-G374
    • Shen, Z.1    Liang, X.2    Rogers, C.Q.3    Rideout, D.4    You, M.5
  • 32
    • 84894348922 scopus 로고    scopus 로고
    • Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver
    • Yin H., Hu M., Liang X., Ajmo J.M., Li X., Bataller R., Odena G., Stevens S.M., You M. Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver. Gastroenterology 2014, 146:801-811.
    • (2014) Gastroenterology , vol.146 , pp. 801-811
    • Yin, H.1    Hu, M.2    Liang, X.3    Ajmo, J.M.4    Li, X.5    Bataller, R.6    Odena, G.7    Stevens, S.M.8    You, M.9
  • 33
    • 84877956229 scopus 로고    scopus 로고
    • Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2
    • Yang C.S., Yuk J.M., Kim J.J., Hwang J.H., Lee C.H., Kim J.M., Oh G.T., Choi H.S., Jo E.K. Small heterodimer partner-targeting therapy inhibits systemic inflammatory responses through mitochondrial uncoupling protein 2. PLoS One 2013, 8.
    • (2013) PLoS One , vol.8
    • Yang, C.S.1    Yuk, J.M.2    Kim, J.J.3    Hwang, J.H.4    Lee, C.H.5    Kim, J.M.6    Oh, G.T.7    Choi, H.S.8    Jo, E.K.9
  • 34
    • 61449106744 scopus 로고    scopus 로고
    • AMPK and the biochemistry of exercise: implications for human and disease
    • Richter E.A., Ruderman N.B. AMPK and the biochemistry of exercise: implications for human and disease. Biochem. J. 2009, 418:261-275.
    • (2009) Biochem. J. , vol.418 , pp. 261-275
    • Richter, E.A.1    Ruderman, N.B.2
  • 35
    • 78349283454 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor alpha target genes
    • Rakhshandehroo M., Knoch B., Müller M., Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 2010:1-20.
    • (2010) PPAR Res. , vol.2010 , pp. 1-20
    • Rakhshandehroo, M.1    Knoch, B.2    Müller, M.3    Kersten, S.4
  • 36
    • 0035823551 scopus 로고    scopus 로고
    • Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta
    • Gervois P., Vu-Dac N., Kleemann R., Kockx M., Dubois G., Laine B., Kosykh V., Fruchart J.C., Kooistra T., Staels B. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J. Biol. Chem. 2011, 276:33471-33477.
    • (2011) J. Biol. Chem. , vol.276 , pp. 33471-33477
    • Gervois, P.1    Vu-Dac, N.2    Kleemann, R.3    Kockx, M.4    Dubois, G.5    Laine, B.6    Kosykh, V.7    Fruchart, J.C.8    Kooistra, T.9    Staels, B.10
  • 38
    • 0033527569 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1
    • Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 1999, 274:32048-32054.
    • (1999) J. Biol. Chem. , vol.274 , pp. 32048-32054
    • Delerive, P.1    De Bosscher, K.2    Besnard, S.3    Vanden Berghe, W.4    Peters, J.M.5    Gonzalez, F.J.6    Fruchart, J.C.7    Tedgui, A.8    Haegeman, G.9    Staels, B.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.